Language Select
Varian Logo

Noona® software application is a smart, cloud-based patient-reported outcomes (PRO) solution. Through the capture and analysis of structured, real-time symptom information, Noona helps clinicians better manage patient symptoms and improve treatment outcomes. Noona is designed to support the everyday work of nurses and physicians in cancer care, helping to increase clinical efficiency and reduce workloads through comprehensive communications tools. Reported benefits include:




Time Savings

Time Saving

Up to 60 minutes per day less time on the phone for nurses

Resource Efficiency

Resource Efficiency

Fewer ER visits as symptoms are treated early

Intuitive App

Intuitive App

Designed with direct input from patients. The average age of Noona patient users is 64-years-old.

Time Savings

High Engagement

90 percent response rate for symptom questionnaires.

Advance Real World Evidence Studies

Advance Real World Evidence Studies

Structured symptom data can be used for clinical trials and improved decision-making.





The patient comes first: Noona’s patient-friendly interface is easy-to-use and can be accessed on any device with a web browser or through its native iPhone® or Android™ app. The secure online interface allows for more efficient and meaningful interaction between patients and clinicians resulting in improved patient outcomes. Patient-reported outcomes have also been linked to improved survival1.

For the care team: Noona incorporates state-of-the-art machine learning algorithms to help prioritize patient care. With Noona, care teams can stay informed of patient health concerns, follow up on critical results between regularly scheduled visits and reduce their workload with a more efficient communication tool.




Noona connects cancer clinics with their patients online.



Learn more about the Noona software application.

Specifications and prerequisites are subject to change without notice. Noona is not available in all markets.

1 Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. Journal of Clinical Oncology 34:557,2016.